Julio Cesar Voltarelli

Summary

Country: Brazil

Publications

  1. ncbi Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus
    Julio C Voltarelli
    Department of Clinical Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil
    JAMA 297:1568-76. 2007
  2. ncbi Stem cell-based therapies and immunomodulatory approaches in newly diagnosed type 1 diabetes
    Carlos Eduardo Barra Couri
    Department of Clinical Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Brazil
    Curr Stem Cell Res Ther 6:10-5. 2011
  3. doi Autologous hematopoietic stem cell transplantation for type 1 diabetes
    Julio C Voltarelli
    Department of Clinical Medicine, Ribeirao Preto School of Medicine, University of Sao Paulo, Ribeirao Preto, Brazil
    Ann N Y Acad Sci 1150:220-9. 2008
  4. ncbi Stem cell therapies for type 1 diabetes mellitus
    Júilio C Voltarelli
    Department of Clinical Medicine, RibeirBo Preto School of Medicine, University of Sao Paulo, Brazil
    Indian J Exp Biol 49:395-400. 2011
  5. pmc Stem cell transplantation for type 1 diabetes mellitus
    Julio C Voltarelli
    Department of Clinical Medicine, Ribeirao Preto School of Medicine, University of Sao Paulo, Brazil
    Diabetol Metab Syndr 1:4. 2009
  6. doi C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus
    Carlos E B Couri
    Department of Clinical Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil
    JAMA 301:1573-9. 2009
  7. ncbi Potential role of stem cell therapy in type 1 diabetes mellitus
    Carlos Eduardo Barra Couri
    Department of Clinical Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil
    Arq Bras Endocrinol Metabol 52:407-15. 2008
  8. doi Autologous stem cell transplantation for early type 1 diabetes mellitus
    Carlos Eduardo Barra Couri
    Department of Clinical Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil
    Autoimmunity 41:666-72. 2008
  9. doi Reappraisal of total body irradiation followed by bone marrow transplantation as a therapy for inflammatory bowel disease
    Dannielle Fernandes Godoi
    Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil
    Immunobiology 218:317-24. 2013
  10. ncbi Influence of fludarabine on the pharmacokinetics of oral busulfan during pretransplant conditioning for hematopoietic stem cell transplantation
    Francine Attié de Castro
    Departamento de Analises Clinicas, Toxicologicas e Bromatologicas, Faculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, Brazil
    J Clin Pharmacol 53:1205-11. 2013

Collaborators

  • R K Burt
  • Rodrigo Jorge
  • Ana Paula Mastropietro
  • Vivian Youssef Khouri
  • Carlos Eduardo Barra Couri
  • Juliana Navarro Ueda Yaochite
  • Dannielle Fernandes Godoi
  • Joao Santana Da Silva
  • Francine Attié de Castro
  • Rubens Camargo Siqueira
  • Fabio Augusto Bronzi Guimarães
  • Carlos E B Couri
  • Belinda Pinto Simões
  • Patricia Vianna Bonini Palma
  • Fabíola Attié de Castro
  • Cristina Ribeiro de Barros Cardoso
  • Marcelo José Barbosa Silva
  • Carolina Caliari-Oliveira
  • Kelen Cristina Ribeiro Malmegrim
  • Denise Brufato Ferraz
  • Mariana Rodrigues Davanso
  • Vera Lucia Lanchote
  • Leandra Naira Zambelli Ramalho
  • Fernando de Queiroz Cunha
  • Virgílio Antônio Rensi Colturato
  • Pauline Rossetti Provinciatto
  • Daniela Carlos
  • Dimas Tadeu Covas
  • Cristina Ribeiro Cardoso
  • Fernando Queiroz Cunha
  • André Marcio Vieira Messias
  • Manoel Antonio Dos Santos
  • Erika Arantes de Oliveira-Cardoso
  • Fabiano Pieroni
  • Daniela A Moraes
  • Milton C Foss
  • Maria C B Oliveira
  • Edson Z Martinez
  • Maria Isabel A Madeira
  • Maria C Foss-Freitas
  • Kelen C R Malmegrim
  • George M N Barros
  • Ana B P L Stracieri
  • Belinda P Simões
  • Carmen Passos Lima
  • Sebastião José Ismael
  • Fabiana Rossetto Morais
  • Paulo Villas Boas Carvalho

Detail Information

Publications16

  1. ncbi Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus
    Julio C Voltarelli
    Department of Clinical Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil
    JAMA 297:1568-76. 2007
    ..Previous animal and clinical studies suggest that moderate immunosuppression in newly diagnosed type 1 DM can prevent further loss of insulin production and can reduce insulin needs...
  2. ncbi Stem cell-based therapies and immunomodulatory approaches in newly diagnosed type 1 diabetes
    Carlos Eduardo Barra Couri
    Department of Clinical Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Brazil
    Curr Stem Cell Res Ther 6:10-5. 2011
    ....
  3. doi Autologous hematopoietic stem cell transplantation for type 1 diabetes
    Julio C Voltarelli
    Department of Clinical Medicine, Ribeirao Preto School of Medicine, University of Sao Paulo, Ribeirao Preto, Brazil
    Ann N Y Acad Sci 1150:220-9. 2008
    ....
  4. ncbi Stem cell therapies for type 1 diabetes mellitus
    Júilio C Voltarelli
    Department of Clinical Medicine, RibeirBo Preto School of Medicine, University of Sao Paulo, Brazil
    Indian J Exp Biol 49:395-400. 2011
    ..However, this response is not maintained and reoccurrence of the disease is major a major challenge to use HSCT in future to prevent or control relapse of DM 1...
  5. pmc Stem cell transplantation for type 1 diabetes mellitus
    Julio C Voltarelli
    Department of Clinical Medicine, Ribeirao Preto School of Medicine, University of Sao Paulo, Brazil
    Diabetol Metab Syndr 1:4. 2009
    ..CONCLUSION: High dose immunosuppression followed by autologous hematopoietic stem cell transplantation is able to induce complete remission (insulin independence) in most patients with early onset type 1 diabetes mellitus...
  6. doi C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus
    Carlos E B Couri
    Department of Clinical Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil
    JAMA 301:1573-9. 2009
    ..8-month follow-up. To investigate if this effect was due to preservation of beta-cell mass, continued monitoring was performed of C-peptide levels after stem cell transplantation in the 15 original and 8 additional patients...
  7. ncbi Potential role of stem cell therapy in type 1 diabetes mellitus
    Carlos Eduardo Barra Couri
    Department of Clinical Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil
    Arq Bras Endocrinol Metabol 52:407-15. 2008
    ....
  8. doi Autologous stem cell transplantation for early type 1 diabetes mellitus
    Carlos Eduardo Barra Couri
    Department of Clinical Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil
    Autoimmunity 41:666-72. 2008
    ....
  9. doi Reappraisal of total body irradiation followed by bone marrow transplantation as a therapy for inflammatory bowel disease
    Dannielle Fernandes Godoi
    Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil
    Immunobiology 218:317-24. 2013
    ....
  10. ncbi Influence of fludarabine on the pharmacokinetics of oral busulfan during pretransplant conditioning for hematopoietic stem cell transplantation
    Francine Attié de Castro
    Departamento de Analises Clinicas, Toxicologicas e Bromatologicas, Faculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, Brazil
    J Clin Pharmacol 53:1205-11. 2013
    ..The results suggest that patients treated with fludarabine should receive 30% lower busulfan doses during conditioning protocols for HSCT. ..
  11. ncbi Use of therapeutic laser for prevention and treatment of oral mucositis
    Vivian Youssef Khouri
    University Hospital, University of Sao Paulo, Ribeirao Preto, SP, Brazil
    Braz Dent J 20:215-20. 2009
    ..01 and p=0.01, respectively). In conclusion, laser reduced the frequency and severity of OM, suggesting that therapeutic laser can be used both as a new form of prevention and treatment of OM...
  12. ncbi Immunological effects of interferon-alpha on chronic myelogenous leukemia
    Fabíola Attié de Castro
    School of Pharmaceutical Sciences of Ribeirão Preto, University of Sao Paulo, Sao Paulo, Brazil
    Leuk Lymphoma 44:2061-7. 2003
    ..Taken together, these results indicate that the therapeutic effect of IFN-alpha in CML-CP is mediated at least in part by immunological mechanisms...
  13. doi Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis
    Juliana Navarro Ueda Yaochite
    Department of Biochemistry and Immunology, School of Medicine of Ribeirao Preto, University of Sao Paulo USP, Ribeirao Preto, SP, Brazil
    Immunobiology 218:338-52. 2013
    ....
  14. pmc Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials
    Carlos Eduardo Barra Couri
    Department of Internal Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil
    Diabetol Metab Syndr 1:19. 2009
    ..From such data, beta cell preservation has become an additional target in the management of T1DM 1...
  15. ncbi Possible mechanisms of retinal function recovery with the use of cell therapy with bone marrow-derived stem cells
    Rubens Camargo Siqueira
    Department of Ophthalmology, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil
    Arq Bras Oftalmol 73:474-9. 2010
    ..In this review, we described these possible mechanisms of recovery of retinal function with the use of cell therapy with bone marrow-derived stem cells...
  16. ncbi Impact of autologous hematopoetic stem cell transplantation on the quality of life of patients with multiple sclerosis
    Fabio Augusto Bronzi Guimarães
    Post graduation Program in Psychology, Faculty of Philosophy, Sciences and Letters of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil
    Arq Neuropsiquiatr 68:522-7. 2010
    ..To evaluate the impact of autologous hematopoetic stem cell transplantation (autoHSCT) in the health related quality of life (HRQL) in patients with multiple sclerosis...